# Pumilio1 (PUM1) Expression, Sickle Cell Anemia, β-thalassemia Intermedia

> **NCT05883254** · — · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 80 (estimated)

## Conditions studied

- Sickle Cell Disease, Beta Thalassemia Intermedia

## Interventions

- **DIAGNOSTIC_TEST:** RNA Binding Protein Pumilio1 (PUM1) Expression by reverse transcriptase quantatative PCR

## Key facts

- **NCT ID:** NCT05883254
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-08
- **Primary completion:** 2026-12
- **Final completion:** 2027-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05883254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05883254, "Pumilio1 (PUM1) Expression, Sickle Cell Anemia, β-thalassemia Intermedia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05883254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*